News Chart Cardiol Therapeutics Inc.

Stocks

CRDL

CA14161Y2006

Biotechnology & Medical Research

Delayed Toronto S.E. 12:19:14 2026-10-22 EDT			5-day change	1st Jan Change
1.650 ^CAD	-0.60%		+3.12%	+25.95%

09-23	Cardiol Therapeutics Achieves Phase III Maveric Enrollment Target Ahead of Schedule and Expands Pivotal Trial	CI
09-23	Cardiol Therapeutics Inc. Achieves MAVERIC Enrollment Target And Expands Pivotal Trial Evaluating CardiolRx	CI

4b5ef330aef986ab36f19cb1.1_-AkRm_9KvJUbMMVEwYW82RkP231MZV6JyqCRX09r0.tLzW5UzFltK_YtdnDRZ_Ma_ToJHekKcRv8X6OUOCh_yEvcPYLeuZhv9h-g~25d8090be04355bec77362b59faada9f